Association of high LDL concentrations with erectile dysfunction from a Mendelian randomization study

Area of Science:

• Cardiovascular Science
• Metabolic Science
• Urology

Background:

• Lipid metabolism is integral to the pathophysiology of erectile dysfunction (ED).
• Understanding the causal relationship between lipid-modulating pathways and ED is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the influence of lipid-lowering drugs on erectile dysfunction using a two-sample Mendelian randomization (MR) approach.
• To assess the potential causal links between specific lipid metabolism genes and ED risk.

Main Methods:

• Employed genetic variants as instrumental variables for lipid-lowering drug targets.
• Utilized the inverse variance-weighted Mendelian randomization (IVW-MR) method for effect estimation.
• Analyzed the association between HMGCR, NPC1L1, and PCSK9 expression and erectile dysfunction.

Main Results:

• A significant positive association was observed between HMGCR expression and the risk of erectile dysfunction (OR = 1.27, 95% CI: 1.03-1.57, P = 0.028).
• No significant causal relationship was detected for NPC1L1 or PCSK9 expression with erectile dysfunction.
• These findings suggest a specific role for HMGCR in ED pathogenesis.

Conclusions:

• HMGCR inhibitors represent a potentially favorable therapeutic strategy for managing erectile dysfunction.
• Targeting HMGCR may offer a novel approach to treating ED, particularly in patients with dyslipidemia.